Chemotherapy Drugs and their Adjuncts
J5 · Effective Sep 16, 2017
39 active Medicare policies list D47.Z1, and 2 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J5 · Effective Sep 16, 2017
J8 · Effective Sep 16, 2017
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Aug 1, 2018
2 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D47.Z1 |
|---|---|---|
| Concert Genetic Testing Oncology: Hematologic Malignancy | Not recorded | Referenced |
| Policy | Effective | Status of D47.Z1 |
|---|---|---|
| Flow Cytometry | Sep 15, 2026 | Covered |
JK · Effective Aug 1, 2018
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J6 · Effective Nov 1, 2022
JK · Effective Nov 1, 2022
J9 · Effective Oct 1, 2015
J6 · Effective May 1, 2017
JK · Effective May 1, 2017
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Nov 27, 2025
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Mar 5, 2026
J6 · Effective Apr 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
J6 · Effective Apr 1, 2026
National · Effective Oct 30, 2025
National · Effective Oct 1, 2025
National · Effective Oct 1, 2025
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026